Loading data
CVSNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 402.07 bn USD | 372.81 bn USD | 357.78 bn USD | 322.47 bn USD | 292.11 bn USD |
| Cost of revenue | 221.17 bn USD | 206.29 bn USD | 217.1 bn USD | 196.89 bn USD | 175.8 bn USD |
| Operating profit | 4.66 bn USD | 8.52 bn USD | 13.74 bn USD | 7.95 bn USD | 13.31 bn USD |
| Interest expense | — | — | 2.66 bn USD | 2.29 bn USD | 2.5 bn USD |
| Profit before tax | 2.14 bn USD | 6.15 bn USD | 11.17 bn USD | 5.84 bn USD | 10.54 bn USD |
| Income tax expense | 408 m USD | 1.56 bn USD | 2.81 bn USD | 1.51 bn USD | 2.55 bn USD |
| Net income (reported basis) | 1.77 bn USD | 4.61 bn USD | 8.34 bn USD | 4.31 bn USD | 8 bn USD |
| Net income attributable to common shareholders | 1.77 bn USD | 4.61 bn USD | 8.34 bn USD | 4.31 bn USD | 8 bn USD |
| Basic earnings per share | 1.4 USD/share | 3.67 USD/share | 6.49 USD/share | 3.29 USD/share | 6.07 USD/share |
| Diluted earnings per share | 1.39 USD/share | 3.66 USD/share | 6.47 USD/share | 3.26 USD/share | 6.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.